TimesSquare Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

TimesSquare Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,656	Closed	-$998K	–	215
2021 Q4	$998K	Sell	8,656 -9,526	-52%	-$2.29M	0.01%	197
2021 Q3	$6.88M	Sell	18,182 -1,102	-6%	-$370K	0.06%	205
2021 Q2	$7.87M	Sell	19,284 -200	-1%	-$92.1K	0.06%	201
2021 Q1	$9.29M	Buy	+19,484	New	+$10.6M	0.08%	195

Other funds holding NEXI

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TimesSquare Capital Management's NEXI Position: Q1 2022 in Review

TimesSquare Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2022, closing a stake of 8,656 shares — an estimated $998K sold.

TimesSquare Capital Management first reported a position in NEXI in Q1 2021 and held it in 4 quarters. The position peaked at $9.29M in Q1 2021. 52 funds tracked by Wall St. Rank hold NEXI as of Q1 2022.

TimesSquare Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
TimesSquare Capital Management sold 8,656 NexImmune, Inc. Common Stock shares in Q1 2022, an estimated $998K.
TimesSquare Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
TimesSquare Capital Management's NexImmune, Inc. Common Stock position peaked at $9.29M in Q1 2021.
52 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2022.

Based on TimesSquare Capital Management's 13F filing for Q1 2022, filed 6 May 2022.